chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 52.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administer Expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) in a 52-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine). On 11-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.  It was reported that expired vaccine were given as booster shot to patient. The vaccines were stored in freezer and took out one to two vial and placed in fridge each day as needed.
Age: 45.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administer Expired Vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer Expired Vaccine) in a 45-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer Expired Vaccine). On 29-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer Expired Vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment medications were provided.  The vaccine was stored in the freezer.
Age: 42.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administration of expired moderna vaccine that were given as booster shot to patient around 490 to 500 people; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration of expired moderna vaccine that were given as booster shot to patient around 490 to 500 people) in a 42-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration of expired moderna vaccine that were given as booster shot to patient around 490 to 500 people). On 29-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administration of expired moderna vaccine that were given as booster shot to patient around 490 to 500 people) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  The vaccines were stored in freezer , they take out one to two vials and placed in fridge each day as needed.  No treatment medications were provided.
Age: 44.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administer Expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) in a 44-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine). On 29-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment information was reported.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine administration; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administration) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 070H21A, 040B21A and 040B21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to animal (cats), Hay fever, ADD and Irritable bowel syndrome.   On 20-Apr-2021 at 9:04 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 18-May-2021 at 9:11 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 24-Jan-2022 at 10:38 AM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 24-Jan-2022 at 10:38 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administration). On 24-Jan-2022 at 10:38 AM, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administration) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered EXPIRED PRODUCT ADMINISTERED (Expired vaccine administration) to be not related.    No concomitant medications were provided.  No treatment medications were provided.  The patient was disclosed of an event related to receiving their Moderna COVID-19 vaccine 4 days beyond the recommended expiration date.  No Adverse event reported.
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired dose administered to 7 patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose administered to 7 patients) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 077C21B) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose administered to 7 patients). On 19-Jan-2022, EXPIRED PRODUCT ADMINISTERED (Expired dose administered to 7 patients) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter stated that they administered 7 doses of an expired vial of Moderna COVID 19 Vaccine to 7 patients on 19 January 2022. The expiry date of vaccine was on 14 January 2022. Date of Vaccination for first and second doses and their lot numbers were unknown. Reporter mentioned no adverse events were observed in any of the patients and stated that no treatment was given to the patients. Patients were not under any concomitant or regular medication.
Age: 51.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administer Expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) in a 51-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine). On 18-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was reported that no treatment was given on the patients. No concomitant medications were reported.
Age: 16.0
Sex: U
Vaccine: FLUX
Symptoms: Cardiovascular disorder, Death
Clinical narrative: Dies of Cardiovascular Disease during Scrimmage; Initial information received on 27-Jan-2022 regarding an unsolicited non-valid social media serious case received from a consumer/non- healthcare professional (hcp).  This case involves a 16 years old (unknown gender) patient who experienced dies of cardiovascular disease during scrimmage while receiving vaccine INFLUENZA VACCINE.  The patient had no medical history, concomitant disease or risk factor. There were no lab data/results available.   On an unknown date, the patient received suspect INFLUENZA VACCINE produced by unknown manufacturer at (unknown: formulation, strength, dose, frequency, lot number, route and administration site) for Flu. Information on the batch number was requested.  On an unknown onset and unspecified latency, the patient "died of cardiovascular disease during scrimmage" (cardiovascular disorder) following the administration of INFLUENZA VACCINE. This event was leading to death.  Reportedly, this is a public post on the Sanofi flu shot campaign Flu Shot Fridays we are assuming the consumer is referring to the Sanofi flu vaccine. Author/Reporter Comment: Have you seen this list?? It goes on and on, and on.. it's happening everywhere, and is NOT normal!! 16 year old dies of Cardiovascular Disease during Scrimmage. It is unknown if the patient experienced any additional symptoms/events.  Final diagnosis was (fatal) dies of cardiovascular disease during scrimmage.  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (Dies of Cardiovascular Disease during Scrimmage).  At time of reporting, the outcome was Fatal for the event dies of cardiovascular disease during scrimmage. It is unknown if an autopsy was done. The cause of death was reported as Cardiovascular disease, unspecified.; Sender's Comments: Sanofi company comment dated 4-Feb-2022: This case concerns a 16 years old adult patient who was Dies of Cardiovascular Disease during Scrimmage, after vaccination with Influenza Vaccine. Time to onset of the event is unknown. Information regarding condition at the time of vaccination, therapy details, latency, medical history, concomitant medications, autopsy findings would be needed to rule out any alternative etiologies. Based on the reported information, role of the individual vaccine cannot be assessed.; Reported Cause(s) of Death: Cardiovascular Disease
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Adnexa uteri pain, Chest pain, Menstrual disorder
Clinical narrative: Ever since I got my second dose Nov 2021 I have had inconsistant chest pains thats not a heart attack related no high blood pressure. Also Ever since I got the vaccine my menstrual cycle has not been the same and have not had my menstrual cycle since  I got the moderna and there is no chance of pregnancy just took a test and its a negative. I have had weird sharp pains where my ovaries would be  and the pain always starts a week after I was supposed to be on my menstrual cycle
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus in left ear. Non-stop buzzing in the ear day and night. Loud enough that I can hear the buzzing in a noisy setting.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: hospitilization
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac electrophysiologic study abnormal, Guillain-Barre syndrome, Radiculopathy
Clinical narrative: Guillain-Barre - case is considered to be very mild and he can continue his workup in the outpatient setting.
Age: 28.0
Sex: M
Vaccine: FLU4
Symptoms: Diplegia
Clinical narrative: Some mild paralysis in the legs that started several hours later in the evening and has continued to this day
Age: 16.0
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Error: Patient Too Young for Vaccine Administered-
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Error: Wrong Dose of Vaccine - Too Low-
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus, Urticaria
Clinical narrative: 1)Hives - On December 27th (13 days after my booster) I broke out in hives all over my body. This was terrible for approx 3 weeks, but I was able to control it with over the counter antihistamines taken every other day. After 3 weeks the hives got somewhat better and I was able to take the antihistamines once every 4 days. It has now been 5 weeks since the hives started. It has not gone away and I am still taking the antihistamines once every 4 days.  I have never had any issues with allergies before this.  2)Tinnitus - Around the same time (Dec 27th), I started to notice Tinnitus in both ears. I have never experienced this before. Over time, it seems that the Tinnitus has gotten worse. It is now February 7th, 2022 and it is very strong and annoying. The Tinnitus is constant all day and night long.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate increased
Clinical narrative: Intermittent rapid heart rate episodes lasting approximately 1 hour and generally occurring multiple times per day lasted from May to December, 2021.
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Diarrhoea, Nausea, SARS-CoV-2 test positive, Vomiting
Clinical narrative: nausea, vomiting, diarrhea.  required supplemental O2 started on remdesivir and decadron
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, COVID-19, Confusional state, Fall, Hypercalcaemia
Clinical narrative: Patient presented to the hospital after falling, confusion, weakness and trouble getting around.  She was admitted for severe hypercalcemia with suspected hyperparathyroidism.  Patient was tested as part of a discharge plan to an ECF and found to be positive for COVID-19 on 1/26/22.  Previously vaccinated with Pfizer 6/18/21 & 7/10/21.  Discharged from the hospital 2/3/22
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hyperparathyroidism, Mobility decreased, SARS-CoV-2 test positive
Clinical narrative: Patient presented to the hospital after falling, confusion, weakness and trouble getting around.  She was admitted for severe hypercalcemia with suspected hyperparathyroidism.  Patient was tested as part of a discharge plan to an ECF and found to be positive for COVID-19 on 1/26/22.  Previously vaccinated with Pfizer 6/18/21 & 7/10/21.  Discharged from the hospital 2/3/22
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cough, Fatigue, SARS-CoV-2 test positive
Clinical narrative: He presents to the ED for evaluation of fatigue. He states he always feels fatigued and was advised in the past to follow up for a sleep study. He has not personally noticed any changes but his children were concerned about him being increasingly more fatigued over the past 2-3 days and advised him to seek medical attention. He does endorse a nonproductive cough that has also been present for the past 2-3 days. He denies any chest pain, shortness of breath, palpitations, lower extremity edema/pain, fever and/or chills. Patient has received 2 doses of the Pfizer COVID vaccine (7/20/21 & 8/10/21)but has not received a booster dose as of yet. Admitted to the hospital 1/28/22.  Discharged 1/31/22.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Blood creatinine normal, Blood lactic acid, Blood potassium decreased, Blood sodium normal, Bundle branch block left
Clinical narrative: Janssen 3/26/21 Patient presented to the ED from skilled nursing facility for altered mental status, electrolyte imbalance and hypothermia with a temp of 91.  White cell count is 7.65, hemoglobin is 7.8, platelet count is 457,000, MCV is 80.1.  Sodium is 141, potassium is 3.0, creatinine is 0.88.  Troponin is 37.  ProBNP is 1110.  Liver function panel is normal.  Lactic acid is 1.3.  SARS COVID-2 virus is detected.  Chest x-ray showed interstitial pulmonary edema.  Electrocardiogram showed sinus rhythm at a rate of 67 beats per minute.  Left bundle-branch block, otherwise negative.  Admit for septic shock.  Patient's status continued to decline and her family opted for hospice treatment.  She was discharged to hospice on 2/1/2022.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Electrocardiogram abnormal, Electrolyte imbalance, General physical health deterioration
Clinical narrative: Janssen 3/26/21 Patient presented to the ED from skilled nursing facility for altered mental status, electrolyte imbalance and hypothermia with a temp of 91.  White cell count is 7.65, hemoglobin is 7.8, platelet count is 457,000, MCV is 80.1.  Sodium is 141, potassium is 3.0, creatinine is 0.88.  Troponin is 37.  ProBNP is 1110.  Liver function panel is normal.  Lactic acid is 1.3.  SARS COVID-2 virus is detected.  Chest x-ray showed interstitial pulmonary edema.  Electrocardiogram showed sinus rhythm at a rate of 67 beats per minute.  Left bundle-branch block, otherwise negative.  Admit for septic shock.  Patient's status continued to decline and her family opted for hospice treatment.  She was discharged to hospice on 2/1/2022.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Haemoglobin decreased, Hypothermia, Liver function test normal, Mean cell volume normal, Mental status changes
Clinical narrative: Janssen 3/26/21 Patient presented to the ED from skilled nursing facility for altered mental status, electrolyte imbalance and hypothermia with a temp of 91.  White cell count is 7.65, hemoglobin is 7.8, platelet count is 457,000, MCV is 80.1.  Sodium is 141, potassium is 3.0, creatinine is 0.88.  Troponin is 37.  ProBNP is 1110.  Liver function panel is normal.  Lactic acid is 1.3.  SARS COVID-2 virus is detected.  Chest x-ray showed interstitial pulmonary edema.  Electrocardiogram showed sinus rhythm at a rate of 67 beats per minute.  Left bundle-branch block, otherwise negative.  Admit for septic shock.  Patient's status continued to decline and her family opted for hospice treatment.  She was discharged to hospice on 2/1/2022.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Platelet count increased, Prohormone brain natriuretic peptide increased, Pulmonary oedema, SARS-CoV-2 test positive, Septic shock
Clinical narrative: Janssen 3/26/21 Patient presented to the ED from skilled nursing facility for altered mental status, electrolyte imbalance and hypothermia with a temp of 91.  White cell count is 7.65, hemoglobin is 7.8, platelet count is 457,000, MCV is 80.1.  Sodium is 141, potassium is 3.0, creatinine is 0.88.  Troponin is 37.  ProBNP is 1110.  Liver function panel is normal.  Lactic acid is 1.3.  SARS COVID-2 virus is detected.  Chest x-ray showed interstitial pulmonary edema.  Electrocardiogram showed sinus rhythm at a rate of 67 beats per minute.  Left bundle-branch block, otherwise negative.  Admit for septic shock.  Patient's status continued to decline and her family opted for hospice treatment.  She was discharged to hospice on 2/1/2022.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Troponin, White blood cell count normal
Clinical narrative: Janssen 3/26/21 Patient presented to the ED from skilled nursing facility for altered mental status, electrolyte imbalance and hypothermia with a temp of 91.  White cell count is 7.65, hemoglobin is 7.8, platelet count is 457,000, MCV is 80.1.  Sodium is 141, potassium is 3.0, creatinine is 0.88.  Troponin is 37.  ProBNP is 1110.  Liver function panel is normal.  Lactic acid is 1.3.  SARS COVID-2 virus is detected.  Chest x-ray showed interstitial pulmonary edema.  Electrocardiogram showed sinus rhythm at a rate of 67 beats per minute.  Left bundle-branch block, otherwise negative.  Admit for septic shock.  Patient's status continued to decline and her family opted for hospice treatment.  She was discharged to hospice on 2/1/2022.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Appendicitis, COVID-19, SARS-CoV-2 test positive, Surgery
Clinical narrative: Patient admitted to the hospital 1/29/22 for abdominal pain.  Was found to have acute appendicitis requiring surgical intervention.   Patient had a recent COVID diagnosis prior to hospitalization and tested positive again on 1/29/22 when tested at the hospital.  Patient was discharged 2/2/22.  Previously vaccinated with Pfizer 5/8/21 & 5/29/21.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram cerebral normal, Anticoagulant therapy, Arrhythmia, Asymptomatic COVID-19, Blood thyroid stimulating hormone normal
Clinical narrative: Presented to the ED for dizziness that she described as her head spinning, worsening with standing relieved by laying down, headache but no other focal neuro deficits.  Patient with dizziness without any other focal neurological deficit.  Initial CT scan without acute intracranial pathology neither ischemia nor hemorrhage. CT angio head, neck without significant stenosis. MRI without acute infarct. Neurologist evaluation done and recommended secondary stroke prevention with xarelto. EKG with bradycardia sinus rhythm and negative initial troponin. Will monitor on telemetry to assess ongoing arrhythmias. Patient now reported hx of afib, started on AC again. labs unremarkable.  Tested positive for COVID but remain asymptomatic and hypoxic. dizziness could be related to COVID. 2D echo preserved EF without valvulopathy. grade 1 diastolic dysfunction TSH normal. will follow orthostatic evaluation. PT/OT cleared patient for home.  Discharged 1/31/22.  Previously vaccinated with Moderna - 3/10/21 & 4/12/21.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cardiac telemetry, Cerebrovascular accident, Computerised tomogram head normal, Diastolic dysfunction
Clinical narrative: Presented to the ED for dizziness that she described as her head spinning, worsening with standing relieved by laying down, headache but no other focal neuro deficits.  Patient with dizziness without any other focal neurological deficit.  Initial CT scan without acute intracranial pathology neither ischemia nor hemorrhage. CT angio head, neck without significant stenosis. MRI without acute infarct. Neurologist evaluation done and recommended secondary stroke prevention with xarelto. EKG with bradycardia sinus rhythm and negative initial troponin. Will monitor on telemetry to assess ongoing arrhythmias. Patient now reported hx of afib, started on AC again. labs unremarkable.  Tested positive for COVID but remain asymptomatic and hypoxic. dizziness could be related to COVID. 2D echo preserved EF without valvulopathy. grade 1 diastolic dysfunction TSH normal. will follow orthostatic evaluation. PT/OT cleared patient for home.  Discharged 1/31/22.  Previously vaccinated with Moderna - 3/10/21 & 4/12/21.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Echocardiogram abnormal, Ejection fraction, Electrocardiogram normal, Headache
Clinical narrative: Presented to the ED for dizziness that she described as her head spinning, worsening with standing relieved by laying down, headache but no other focal neuro deficits.  Patient with dizziness without any other focal neurological deficit.  Initial CT scan without acute intracranial pathology neither ischemia nor hemorrhage. CT angio head, neck without significant stenosis. MRI without acute infarct. Neurologist evaluation done and recommended secondary stroke prevention with xarelto. EKG with bradycardia sinus rhythm and negative initial troponin. Will monitor on telemetry to assess ongoing arrhythmias. Patient now reported hx of afib, started on AC again. labs unremarkable.  Tested positive for COVID but remain asymptomatic and hypoxic. dizziness could be related to COVID. 2D echo preserved EF without valvulopathy. grade 1 diastolic dysfunction TSH normal. will follow orthostatic evaluation. PT/OT cleared patient for home.  Discharged 1/31/22.  Previously vaccinated with Moderna - 3/10/21 & 4/12/21.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoxia, Laboratory test normal, Magnetic resonance imaging head normal, SARS-CoV-2 test positive, Sinus bradycardia
Clinical narrative: Presented to the ED for dizziness that she described as her head spinning, worsening with standing relieved by laying down, headache but no other focal neuro deficits.  Patient with dizziness without any other focal neurological deficit.  Initial CT scan without acute intracranial pathology neither ischemia nor hemorrhage. CT angio head, neck without significant stenosis. MRI without acute infarct. Neurologist evaluation done and recommended secondary stroke prevention with xarelto. EKG with bradycardia sinus rhythm and negative initial troponin. Will monitor on telemetry to assess ongoing arrhythmias. Patient now reported hx of afib, started on AC again. labs unremarkable.  Tested positive for COVID but remain asymptomatic and hypoxic. dizziness could be related to COVID. 2D echo preserved EF without valvulopathy. grade 1 diastolic dysfunction TSH normal. will follow orthostatic evaluation. PT/OT cleared patient for home.  Discharged 1/31/22.  Previously vaccinated with Moderna - 3/10/21 & 4/12/21.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Troponin normal, Vertigo
Clinical narrative: Presented to the ED for dizziness that she described as her head spinning, worsening with standing relieved by laying down, headache but no other focal neuro deficits.  Patient with dizziness without any other focal neurological deficit.  Initial CT scan without acute intracranial pathology neither ischemia nor hemorrhage. CT angio head, neck without significant stenosis. MRI without acute infarct. Neurologist evaluation done and recommended secondary stroke prevention with xarelto. EKG with bradycardia sinus rhythm and negative initial troponin. Will monitor on telemetry to assess ongoing arrhythmias. Patient now reported hx of afib, started on AC again. labs unremarkable.  Tested positive for COVID but remain asymptomatic and hypoxic. dizziness could be related to COVID. 2D echo preserved EF without valvulopathy. grade 1 diastolic dysfunction TSH normal. will follow orthostatic evaluation. PT/OT cleared patient for home.  Discharged 1/31/22.  Previously vaccinated with Moderna - 3/10/21 & 4/12/21.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Dyspnoea, Fatigue, Gastrointestinal haemorrhage
Clinical narrative: Patient presents with a 2 week declined marked by shortness of breath and fatigue.  He was noted to have melenic stool at the extended care facility.  On admission his hemoglobin was 7.8 and then the repeat hemoglobin after 3 hours came back 6.1 . Patient has a remote history of peptic ulcer disease.  Colonoscopy 6 months ago unremarkable except for diverticulosis and benign polyps.  Patient denies bright red blood per rectum.  Patient is not on anticoagulation.  Patient denies use of NSAID or aspirin products.  Pt found to be COVID +, no hypoxia, afebrile, Chest xray stable airspace disease.  Pt treated for GI bleed and discharged 2/3/22.  Previously vaccinated Moderna 3/23/21, 4/20/21, 8/19/21
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Haemoglobin decreased, Melaena, SARS-CoV-2 test positive
Clinical narrative: Patient presents with a 2 week declined marked by shortness of breath and fatigue.  He was noted to have melenic stool at the extended care facility.  On admission his hemoglobin was 7.8 and then the repeat hemoglobin after 3 hours came back 6.1 . Patient has a remote history of peptic ulcer disease.  Colonoscopy 6 months ago unremarkable except for diverticulosis and benign polyps.  Patient denies bright red blood per rectum.  Patient is not on anticoagulation.  Patient denies use of NSAID or aspirin products.  Pt found to be COVID +, no hypoxia, afebrile, Chest xray stable airspace disease.  Pt treated for GI bleed and discharged 2/3/22.  Previously vaccinated Moderna 3/23/21, 4/20/21, 8/19/21
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Chronic obstructive pulmonary disease, Condition aggravated, Dyspnoea
Clinical narrative: Patient was admitted for worsening respiratory failure and respiratory distress.  Does have COPD and chronically wears 2-4 L nasal cannula at baseline.  Did test positive for COVID-19  Chest x-ray did not show acute intrathoracic process but did show significant emphysematous changes.  At most required 3 L nasal cannula to maintain oxygenation.  Had significant pan expiratory and inspiratory wheezes. Received remdesivir and Solu-Medrol. Also received bronchodilator therapy.  Had drastic improvement in her wheezing and her shortness of breath.  Weaned to her baseline oxygenation of 2 L nasal cannula.  COPD Exacerbation in addition to COVID.  Discharged home 2/2/22. Previously vacc: Pfizer 3/18/21, 4/8/21, 12/20/21
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Emphysema, Pain, Respiratory distress, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Patient was admitted for worsening respiratory failure and respiratory distress.  Does have COPD and chronically wears 2-4 L nasal cannula at baseline.  Did test positive for COVID-19  Chest x-ray did not show acute intrathoracic process but did show significant emphysematous changes.  At most required 3 L nasal cannula to maintain oxygenation.  Had significant pan expiratory and inspiratory wheezes. Received remdesivir and Solu-Medrol. Also received bronchodilator therapy.  Had drastic improvement in her wheezing and her shortness of breath.  Weaned to her baseline oxygenation of 2 L nasal cannula.  COPD Exacerbation in addition to COVID.  Discharged home 2/2/22. Previously vacc: Pfizer 3/18/21, 4/8/21, 12/20/21
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Wheezing
Clinical narrative: Patient was admitted for worsening respiratory failure and respiratory distress.  Does have COPD and chronically wears 2-4 L nasal cannula at baseline.  Did test positive for COVID-19  Chest x-ray did not show acute intrathoracic process but did show significant emphysematous changes.  At most required 3 L nasal cannula to maintain oxygenation.  Had significant pan expiratory and inspiratory wheezes. Received remdesivir and Solu-Medrol. Also received bronchodilator therapy.  Had drastic improvement in her wheezing and her shortness of breath.  Weaned to her baseline oxygenation of 2 L nasal cannula.  COPD Exacerbation in addition to COVID.  Discharged home 2/2/22. Previously vacc: Pfizer 3/18/21, 4/8/21, 12/20/21
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Dyspnoea, Oxygen saturation decreased, Positive airway pressure therapy, Respiratory failure
Clinical narrative: Pt presented to the hospital after acute SOB x1 day, recently discharged from HCF.  Her oxygen levels were very low - she was placed on BiPAP ventilation and now on 50% FiO2.  She was admitted for hypoxic respiratory failure.  On admission 1/19/2022 the patient tested negative for COVID-19.  She was re-tested on 1/26/2022 and found to be COVID +.  Patient had been previously vaccinated and boosted. Moderna 2/26/21 & 3/26/21; Pfizer Booster 11/13/21.  Pt discharged 2/5/22
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Pt presented to the hospital after acute SOB x1 day, recently discharged from HCF.  Her oxygen levels were very low - she was placed on BiPAP ventilation and now on 50% FiO2.  She was admitted for hypoxic respiratory failure.  On admission 1/19/2022 the patient tested negative for COVID-19.  She was re-tested on 1/26/2022 and found to be COVID +.  Patient had been previously vaccinated and boosted. Moderna 2/26/21 & 3/26/21; Pfizer Booster 11/13/21.  Pt discharged 2/5/22
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Dyspnoea, Hypotension, Pneumonia
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 04/27/2021.  60 y/o with PMHx of prostate CA with bone mets, AAA, HTN, GERD, Depression, Chronic pain, CAD, PTCA with stents x2, HLD, Type 2 DM presents to ED from oncologist's office with c/o Hypotension.  Room air sats 89%, CXR-increased hazy alveolar density edema or infection.  Initial Covid test negative on admission 2/3/2022.  During stay pt with increasing SOB and productive cough, tested again on 2/7/2022 and test now positive.  Pt currently on IV ABx and steroids, now to be started on Remdesivir.
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Productive cough, Pulmonary oedema, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 04/27/2021.  60 y/o with PMHx of prostate CA with bone mets, AAA, HTN, GERD, Depression, Chronic pain, CAD, PTCA with stents x2, HLD, Type 2 DM presents to ED from oncologist's office with c/o Hypotension.  Room air sats 89%, CXR-increased hazy alveolar density edema or infection.  Initial Covid test negative on admission 2/3/2022.  During stay pt with increasing SOB and productive cough, tested again on 2/7/2022 and test now positive.  Pt currently on IV ABx and steroids, now to be started on Remdesivir.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Agitation, Asthenia, Blood creatinine increased, Blood sodium increased, Blood urea increased
Clinical narrative: Patient is a 80-year-old male patient with a history of dementia who presents to the emergency department by ambulance from a local assisted living for increased tremors, mental status change and weakness.  Patient was diagnosed with Covid a week and a half ago and facility states over the last 3 days he has not been eating and has had increased weakness.  Patient does get agitated at baseline.  He is agitated upon arrival to the emergency department.  No fever. Associated Symptoms: agitation, weakness
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray, Hypophagia, Mental status changes, Tremor
Clinical narrative: Patient is a 80-year-old male patient with a history of dementia who presents to the emergency department by ambulance from a local assisted living for increased tremors, mental status change and weakness.  Patient was diagnosed with Covid a week and a half ago and facility states over the last 3 days he has not been eating and has had increased weakness.  Patient does get agitated at baseline.  He is agitated upon arrival to the emergency department.  No fever. Associated Symptoms: agitation, weakness
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Troponin
Clinical narrative: Patient is a 80-year-old male patient with a history of dementia who presents to the emergency department by ambulance from a local assisted living for increased tremors, mental status change and weakness.  Patient was diagnosed with Covid a week and a half ago and facility states over the last 3 days he has not been eating and has had increased weakness.  Patient does get agitated at baseline.  He is agitated upon arrival to the emergency department.  No fever. Associated Symptoms: agitation, weakness
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Blood creatinine increased, COVID-19, COVID-19 pneumonia
Clinical narrative: Moderna COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 02/06/21 and 03/04/2021. COVID-19 + at outside facility 1/6/22. COVID-19 + 1/13/22. Presented to ED on 1/21/22 for 10 days of COVID-19 symptoms including progressive fatigue and SOB. Admitted for acute hypoxemic respiratory failure due to Covid-19 PNA.. In ED had O2 sat of 93% at rest but 86% after exertion and was placed on 2L O2. Found to have AKI w/ Cr >2 and was given 2L of fluids. Treated with dexamethasone. Continued to deteriorate, status changed to DNAR/COT. Expired 1/25/22.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Death, Dyspnoea, Fatigue, General physical health deterioration, Malaise
Clinical narrative: Moderna COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 02/06/21 and 03/04/2021. COVID-19 + at outside facility 1/6/22. COVID-19 + 1/13/22. Presented to ED on 1/21/22 for 10 days of COVID-19 symptoms including progressive fatigue and SOB. Admitted for acute hypoxemic respiratory failure due to Covid-19 PNA.. In ED had O2 sat of 93% at rest but 86% after exertion and was placed on 2L O2. Found to have AKI w/ Cr >2 and was given 2L of fluids. Treated with dexamethasone. Continued to deteriorate, status changed to DNAR/COT. Expired 1/25/22.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Moderna COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 02/06/21 and 03/04/2021. COVID-19 + at outside facility 1/6/22. COVID-19 + 1/13/22. Presented to ED on 1/21/22 for 10 days of COVID-19 symptoms including progressive fatigue and SOB. Admitted for acute hypoxemic respiratory failure due to Covid-19 PNA.. In ED had O2 sat of 93% at rest but 86% after exertion and was placed on 2L O2. Found to have AKI w/ Cr >2 and was given 2L of fluids. Treated with dexamethasone. Continued to deteriorate, status changed to DNAR/COT. Expired 1/25/22.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cerebral infarction, Computerised tomogram head abnormal, Facial asymmetry, Facial paralysis
Clinical narrative: A 74-year-old male presents the emergency department via EMS complaining of left-sided weakness.  Per the roommates at patient's home they heard him fall around 4 AM out of his bed and went to help him out back in bed.  However, he never got up at his normal time and when his roommates went and checked on him he had left-sided weakness and was staring to the right.  The roommates were contacted and states that he had trouble walking at the 4 AM time.  They said the last time they saw him like his original self was yesterday evening.  The patient has no history of diabetes but is a daily smoker.  The patient is supposed to be taking aspirin and blood pressure medications but the roommates are unsure if he has been taking them.  The patient the patient complains of facial symmetry weakness and numbness.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Gait disturbance, Gaze palsy, Hemiparesis, Hypoaesthesia
Clinical narrative: A 74-year-old male presents the emergency department via EMS complaining of left-sided weakness.  Per the roommates at patient's home they heard him fall around 4 AM out of his bed and went to help him out back in bed.  However, he never got up at his normal time and when his roommates went and checked on him he had left-sided weakness and was staring to the right.  The roommates were contacted and states that he had trouble walking at the 4 AM time.  They said the last time they saw him like his original self was yesterday evening.  The patient has no history of diabetes but is a daily smoker.  The patient is supposed to be taking aspirin and blood pressure medications but the roommates are unsure if he has been taking them.  The patient the patient complains of facial symmetry weakness and numbness.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Intensive care, NIH stroke scale, Neurological symptom, SARS-CoV-2 test positive, Troponin increased
Clinical narrative: A 74-year-old male presents the emergency department via EMS complaining of left-sided weakness.  Per the roommates at patient's home they heard him fall around 4 AM out of his bed and went to help him out back in bed.  However, he never got up at his normal time and when his roommates went and checked on him he had left-sided weakness and was staring to the right.  The roommates were contacted and states that he had trouble walking at the 4 AM time.  They said the last time they saw him like his original self was yesterday evening.  The patient has no history of diabetes but is a daily smoker.  The patient is supposed to be taking aspirin and blood pressure medications but the roommates are unsure if he has been taking them.  The patient the patient complains of facial symmetry weakness and numbness.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Electrocardiogram, Hypoaesthesia, Laboratory test
Clinical narrative: Post vaccination patient complained of chest heaviness, vitals were taken BP 97/66, Pulse 73, O2 97% on RA, RR 20/min, patient was monitored for an additional 15 mins and vitals were retaken BP 113/75, pulse 66, O2 99% on RA and RR 16/min. Patient then verbalized complaining of numbness on right side of hemiface and was taken to the Emergency Department for further evaluation.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Fall, Intervertebral disc space narrowing, Joint injury, Laboratory test abnormal, Spinal cord disorder
Clinical narrative: Patient reported to the ED on  01/16/2022 and  states that approximately 3 AM this morning she was walking to get up to the bathroom tripped and fell over a toy and landed on her right side, specifically her hip.  She denies hitting her head or neck.  This occurred after receiving covid vaccine 01/06/2022. Per guidelines, all hospitalizations are recorded.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Spondylolisthesis
Clinical narrative: Patient reported to the ED on  01/16/2022 and  states that approximately 3 AM this morning she was walking to get up to the bathroom tripped and fell over a toy and landed on her right side, specifically her hip.  She denies hitting her head or neck.  This occurred after receiving covid vaccine 01/06/2022. Per guidelines, all hospitalizations are recorded.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Hypoxia, Oedema peripheral, Pleural effusion, Prostate cancer
Clinical narrative: CLINICAL IMPRESSION 1. Hypoxemia 2. COVID-19 virus infection 3. Bilateral pleural effusion 4. Lower extremity edema  5. Prostate cancer
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: positive COVID
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Psoriasis
Clinical narrative: Psoriasis
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Brain natriuretic peptide normal, COVID-19, Chest X-ray abnormal, Dyspnoea, Exposure to SARS-CoV-2
Clinical narrative: Patient is a 52-year-old male with past medical history of hypertension, PE on Xarelto, lobectomy d/t GSW in 1988 presenting for SOB and B/L foot swelling. Patient states he has had worsening shortness of breath over the past 1 week. He notes progressively worsening bilateral foot swelling as well over this timeframe. States the right foot is swelling worse than the left. He denies any associated chest pain. No fevers or chills. He does note associated dry cough. No nausea, vomiting or diarrhea. Patient is fully vaccinated for COVID 19, however states he was exposed to the virus about 1 week ago; just prior to symptom onset. He reports religious compliance with Xarelto; denies any missed doses. Nonsmoker. No hx cardiac disease. Pt has home O2 for use as needed since lobectomy, however does not normally require its use.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza A virus test negative, Influenza B virus test, Oedema peripheral, Peripheral swelling, Productive cough
Clinical narrative: Patient is a 52-year-old male with past medical history of hypertension, PE on Xarelto, lobectomy d/t GSW in 1988 presenting for SOB and B/L foot swelling. Patient states he has had worsening shortness of breath over the past 1 week. He notes progressively worsening bilateral foot swelling as well over this timeframe. States the right foot is swelling worse than the left. He denies any associated chest pain. No fevers or chills. He does note associated dry cough. No nausea, vomiting or diarrhea. Patient is fully vaccinated for COVID 19, however states he was exposed to the virus about 1 week ago; just prior to symptom onset. He reports religious compliance with Xarelto; denies any missed doses. Nonsmoker. No hx cardiac disease. Pt has home O2 for use as needed since lobectomy, however does not normally require its use.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary oedema, Respiratory syncytial virus test negative, SARS-CoV-2 test positive, Ultrasound Doppler, Ultrasound scan normal
Clinical narrative: Patient is a 52-year-old male with past medical history of hypertension, PE on Xarelto, lobectomy d/t GSW in 1988 presenting for SOB and B/L foot swelling. Patient states he has had worsening shortness of breath over the past 1 week. He notes progressively worsening bilateral foot swelling as well over this timeframe. States the right foot is swelling worse than the left. He denies any associated chest pain. No fevers or chills. He does note associated dry cough. No nausea, vomiting or diarrhea. Patient is fully vaccinated for COVID 19, however states he was exposed to the virus about 1 week ago; just prior to symptom onset. He reports religious compliance with Xarelto; denies any missed doses. Nonsmoker. No hx cardiac disease. Pt has home O2 for use as needed since lobectomy, however does not normally require its use.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID BREAKTHROUGH CASE
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: Injection arm was extremely sore with some swelling for 2-4 days after vaccine received.  Soreness continued for 2 weeks.
Age: 84.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID BREAKTHROUGH CASE
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: hospitalization due to covid-19
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Death
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: During the administration of the patient's 2nd dose of Modena vaccine, the needle detached from the syringe. This caused the patient to not receive the full dosage of the vaccine.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Injection site pain, Lethargy
Clinical narrative: Fatigue, Injection site pain, joint pain (full body), muscle cramps (full Body), Fever, Lethargic, chills. Treated with Ibuprofen, lasted 2 days
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Muscle spasms, Pyrexia
Clinical narrative: Fatigue, Injection site pain, joint pain (full body), muscle cramps (full Body), Fever, Lethargic, chills. Treated with Ibuprofen, lasted 2 days
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Fatigue, Headache, Injection site pain, Lymphadenopathy
Clinical narrative: Injection site soreness, arm soreness, swollen lymph nodes, mild fever, severe body aches - felt like it was in my bones, headache, fatigue, vertigo.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Pyrexia, Vertigo
Clinical narrative: Injection site soreness, arm soreness, swollen lymph nodes, mild fever, severe body aches - felt like it was in my bones, headache, fatigue, vertigo.
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dysstasia, Gait disturbance, Muscular weakness
Clinical narrative: lower extremity weakness and difficulty standing and walking for months
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Computerised tomogram, Dizziness, Echocardiogram, Electrocardiogram
Clinical narrative: lower extremity weakness and difficulty standing and walking for months
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Electromyogram, Inappropriate schedule of product administration, Magnetic resonance imaging, Seizure, Sensory disturbance
Clinical narrative: lower extremity weakness and difficulty standing and walking for months
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Tilt table test
Clinical narrative: lower extremity weakness and difficulty standing and walking for months